MicroRNAs (miRNAs), one of the most abundant groups of regulatory non coding RNAs in multicellular organisms, play important roles in many fundamental cellular processes. More than four hundred miRNAs have been identified in humans and the deregulated expression of miR-NA has been also shown in many cancers. Despite the postulated involvement of miRNAs in tumourigenesis, there are only a few examples where an oncogene or a tumour suppressor has been identified as a miRNA target. Here, we present an in silico analysis of potential miR-NA-MYC interactions. We showed evidence for the regulation of c-MYC, one of the most potent and frequently deregulated oncogenes, via the predicted binding site in transcriptional and post transcriptional regions. In this work, bioinformatics approach for the prediction and validation of possible targets for miRNAs has been used. A list of putative targets is available and validation of which would be experimentally validated. According to various studies, miRNAs has critical role(s) in various regulatory processes such as embryonic development, protein secretion, viral infection, cell selfrenewal/differentiation, cell division and cell proliferation (4) . Several scientific reports stated that many miRNAs, referred to as onco/tumor suppressor miRNAs, play role (s) in the development of various human malignancies (5-8). Aberrant expression of miRNAs involved to carcinogenesis by promoting the expression of protooncogenes or by inhibiting the expression of tumor suppressor genes (3). In addition, it is about 50% of genes that encoding miRNAs are located in cancer associated genomic regions (CAGR) or fragile sites (2) . Various types of leukemia including: acute lymphoblastic leukemia (ALL), Acute myeloid leukemia (AML) and Chronic lymphocytic leukemia (CLL) has been researched extensively from miRNAs point of view and currently it has been identified several miRNAs involved in all types of leukemia (3). miR-15a-16-1 was the first miRNAs identified as regulator of CLL (9). Currently there are several miRNAs identified and verified in different type of leukemia cancers (10). miRNAsMiRNAs not only arouse interest among researchers studying molecular mechanism and also gene regulation in different type of malignancies but also they theoretically represent therapeutic targets.
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Material and Methods

A: Computational approach to miRNAs gene finding
The UTR sequences were retrieved from GenBank. The current GeneBank format was converted to a FASTA file. In order to identify potential and possible hairpin structures of miRNAs genes in MYC within the area of interest (5' UTR, 3' UTR, iIntronic and promoter), SCC profiler (13) and miPRED (14) online classifier (http://www.bioinf.seu.edu.cn/ miRNA) programs were employed. For the identification of putative miRNAs p r e c u r s o r s i n MYC i nt r ons CIDmiRNA was used along with the prediction of Dor sha pr ocessi ng si t es using Microprocessor SVM program (15, 16).
Hence, search for new miRNAs with computational approaches could be useful for better understanding of molecular pathways as well as possible new drugs (11). MYC plays a role as transcription factor that involved in cell cycle and cell growth by acting downstream of many ligand membrane receptor complexes and signal transduction pathways. (12). MYC is also a proto-oncogene that contributes to the genesis of many human cancers (Figure 1 ) (11). Currently there are strong evidences that MYC has critical roles in molecular pathways involved in Hodgkin lymphomas and also chronic lymphocytic leukemia (CLL) (12). Over expression of MYC in B lymphocytes is to be sufficient to increase cell growth that could be unlinked from cell proliferation. In addition, its central role in the growth programs of T lymphocytes. These evidences demonstrate necessity of study on common miRNAs in different leukemia types as possible regulator of MYC. In this study, at the first phase we evaluated MYC genome; 3' UTR, 5' UTR and also promoter to find possible new miRNAs (s). In the second phase, potential of common miRNAs in different leukemia types for possible interaction with MYC has been evaluated. (23) o n l i n e t o o l s . D i a n a -mi r p at h ( 24) and geneset2miRNA (25) online tools used to find the pathways in which MYC-miRNAs is involved. Also, for extraction of common miRNAs in different types of leukemia cancers miRCancer and dbDEMC were developed (25, 26). The basis of the assumption that the epistatically interacting genes operated in the same pathway, to search for the co-expression of miRNA target genes with miRNA host gene, GENEMANIA online tool was used (27). www.thecancerpress.com
Results and Discussion
The goal of the bioinformatics analysis was to find potential binding sites in the set of human MYC oncogene. In humans, as in other animals, the miRNA regulation is accomplished by binding the miRNAs predominantly to the 3' untranslated region ( ression profile of miRNAs from cancer tissues has been suggested to be prognostic concerning the speed of cancer development and its malignancy. A correlation between the expression of particular miRNAs and their effects on target oncogenes followed by tumourigenesis is beginning to gain evidence. Of particular interest is the possibility that the growth of cancer cells can be repressed by artificial modulation of the level of miRNAs. Despite the accelerated research interest in the miRNA-regulation, there are only a few examples where an oncogene or a tumour suppressor has been identified as a miRNA target and the regulatory www.thecancerpress.com
